We also found that MET suppressed the proliferation and invasion of drug‐resistant breast cancer cells by increasing the expression and cell membrane localization of SCRIB, which enhanced the interaction of SCRIB with MST1 and LATS1, and inhibited YAP nuclear localization and transcriptional activity. Here, LATS1 is linked to breast cancer.